NCT06195345

Brief Summary

This is an observational study in patients who require clinical anesthesia. The main purpose of this study is to understand whether there are differences in the cerebral blood flow, and oxygen metabolism affected by different types of anesthesia. Subjects who require clinical anesthesia for a clinical MRI and for whom the use of anesthetics for the exam are in clinical equipoise are asked to join the study. All eligible subjects will be asked to provide informed consent before participating in the study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
116mo left

Started Nov 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Nov 2018Nov 2035

Study Start

First participant enrolled

November 1, 2018

Completed
5.1 years until next milestone

First Submitted

Initial submission to the registry

December 22, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 8, 2024

Completed
6.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2030

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2035

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

12 years

First QC Date

December 22, 2023

Last Update Submit

April 24, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in cerebral blood flow (ml blood/100g/min)

    Phase contrast (PC) acquisition via MRI will be used to assess any impact of anesthesia on cerebral blood flow.

    Time points over which the change is assessed: change from (1) start of MRI, through (2) MRI completion, an average of 60 minutes.

  • Change in cerebral metabolic rate of oxygen (ml O2/100g/min)

    T2 relaxation under spin tagging (TRUST) acquisition via MRI will be used to assess any impact of anesthesia on cerebral metabolic rate of oxygen.

    Time points over which the change is assessed: change from (1) start of MRI, through (2) MRI completion, an average of 60 minutes.

Study Arms (1)

Pediatric Patients

Children scheduled for clinical MR imaging.

Diagnostic Test: MR Imaging

Interventions

MR ImagingDIAGNOSTIC_TEST

MR imaging pertaining to the patient and project (ICHOR 1)

Also known as: MRI, Medical Imaging
Pediatric Patients

Eligibility Criteria

Age1 Minute - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Neonates and young children

You may qualify if:

  • Individuals who are able to tolerate an MRI.
  • Are patients scheduled for a clinically indicated MRI.
  • Between birth and up to 18 years.

You may not qualify if:

  • Presence of an MRI-incompatible device or implant (e.g. pacemakers, stents)
  • Unable to tolerate the enclosed spaces and loud noises for the duration of time in scanner required to obtain an MRI.
  • Preterm infants less than 25 weeks
  • Any patient who is clinically too unstable to extend their MRI by up-to 7.5 minutes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital Los Angeles

Los Angeles, California, 90027, United States

RECRUITING

MeSH Terms

Conditions

Brain Injuries, TraumaticHypoxia-Ischemia, Brain

Interventions

Magnetic Resonance ImagingDiagnostic Imaging

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesBrain IschemiaCerebrovascular DisordersHypoxia, BrainVascular DiseasesCardiovascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TomographyDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Matthew Borzage, PhD

    Children's Hospital Los Angeles

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hannah E Wiseman, MPH

CONTACT

Matthew T Borzage, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 22, 2023

First Posted

January 8, 2024

Study Start

November 1, 2018

Primary Completion (Estimated)

November 1, 2030

Study Completion (Estimated)

November 1, 2035

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Locations